Primary record
(4aS,4bR,5S,6aS,6bS,9aR,10aS,10bS,12S)-4b,12-Difluoro-5-hydroxy-6b-(hydroxyacetyl)-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H,8H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
- 库存
- 8,696 克
- 纯度
- 99.1 %
- CAS
- 67-73-2
化合物标识与属性
- CAS
- 67-73-2
- PubChem CID
- 6215
- SMILES
- C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@@H]4[C@]2(OC(O4)(C)C)C(=O)CO)C[C@@H](C5=CC(=O)C=C[C@@]53C)F)F)O
- Canonical SMILES
- CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1
名称与同义词
- FLUOCINOLONE ACETONIDE
- Synalar
- Fluonid
- Flupollon
- Synandone
- Flucinar
- Synamol
- Jellin
- Synandrone
- Coriphate
- Fluovitif
- Percutina
- Dermalar
- Radiocin
- Retisert
- Tefunote
- Flucort
- Localyn
- Sinalar
- Synemol
- Synotic
- Synsac
- Fluotrex
- Omniderm
- Fluocet
- Cortiplastol
- Derma-smoothe/fs
- Localyn Syntex
- Prodermin
- Iluvien
- Synalar-HP
- Capex
- Fs Shampoo
- 67-73-2
- fluocinolone
- Neo-Synalar
- Fluocinolonacetonidum
- Fluzon
- Oto-synalar
- flucinolone
- Dermotic
- Jellisoft
- Medidur
- Dermatin (steroid)
- Fluocinoloni acetonidum
- Co Fluocin
- Cortiespec
- Alvadermo
- Dermatin
- Fluodermo
- Flurosyn
- Flusolgen
- Gelidina
- Polysiral
- Acetonide de fluocinolone
- Fluocid
- Fluvean
- Synalar HP
- Derma Smooth FS
- Flucinolone acetonide
- Fluocinolone 16,17-acetonide
- Synalar fte
- Mixture Name
- Synalar-n
- Co-Fluocin
- Retisert (TN)
- Flucort-L
- Flucort-N
- Fluocinoloneacetonide
- Fluocet (TN)
- Synalar (TN)
- Tri-Luma
- Derma-Smooth FS
- -one
- Flac Otic Oil
- Fluocinolonacetonid
- Fluocinolide (acetate)
- YUTIQ
- Fluzon [Steroid]
- acetonido de fluocinolona
- Acetonida de fluocinolona
- component of Neo-Synalar
- Fluocinolone (Acetonide)
- Fluortriamcinolone Acetonide
- Acetonide, Fluocinolone
- 6alpha-Fluorotriamcinolone acetonide
- Fluocinoloe Acetonide
- FLAC
- Flucort-N (TN)
- fluocinolone-acetonide
- NOXIPAK
- XILAPAK
- 6.Alpha.,9-Difluoro
- Fluocinolone acetonide [DCIT]
- RS-1401 AT
- C24H30F2O6
- fluocinolone (alcohol)
- fluocinolone acetonide oil
- 0CD5FD6S2M
- RefChem:55208
- UNII-0CD5FD6S2M
- DTXSID0040674
- Synalar Cream Veterinary
- NSC-92339
- AC1Q6ACL
- RS 1401AT
- 6.alpha.,17-acetonide
- Opera_ID_1295
- Acetonide, Fluortriamcinolone
- CCRIS 3250
- Fluocinolone Acetonide RS
- Fluocinoloni acetonidum [INN-Latin]
- Fluocinolone acetonide CRS
- CHEMBL989
- D02QJH
- Synalar Solution Veterinary
- HSDB 3083
- AC1L1M1L
- MLS000028545
- MLS001076276
- SCHEMBL4795
- FEBLZLNTKCEFIT-VSXGLTOVSA-N
- Fluocinolone acetonide - BP
- FLUOCINONIDE ACETONIDE
- MFCD00010525
- DTXCID8020674
- Fluocinolone acetonide (Flucort-N)
- CHEBI:31623
- NSC92339
- ARONIS24561
- Fluocinolone Acetonide Topical
- Acetonide de fluocinolone [INN-French]
- EINECS 200-668-5
- Fluocinolone Acetonide 0.01%
- fluocinolone acetonide dihydrate
- NSC 92339
- Acetonida de fluocinolona [INN-Spanish]
- GTPL7077
- orb1310684
- orb3025531
- 6?-Fluorotriamcinolone acetonide
- ERK5-1F03
- HY-B0415R
- C05AA10
- CID6215
- D07AC04
- EBD4852
- Fluocinolone acetonide [USAN:INN:JAN]
- MSK2245
- S01BA15
- S02BA08
- Fluocinolone acetonide(Flucort-N)
- HMS2090I14
- HMS2230D13
- HMS3259G12
- HMS3715J11
- 6.alpha.-Fluorotriamcinolone acetonide
- FLUOCINOLONE ACETONIDE [MI]
- CID:6215
- HY-B0415
- ydroxyprednisolone 16,17-acetonide
- ZINC3977981
- Fluocinolone (Acetonide) (Standard)
- FLUOCINOLONE ACETONIDE [INN]
- FLUOCINOLONE ACETONIDE [JAN]
- Tox21_110869
- Tox21_302364
- AC-429
- AC1069
- AN-252
- AR-1H0758
- EBC-27131
- FLUOCINOLONE ACETONIDE [HSDB]
- FLUOCINOLONE ACETONIDE [USAN]
- FLUOCINOLONE ACETONIDE and UREA
- MSK2245-100A
- s2470
- FLUOCINOLONE ACETONIDE [VANDF]
- SMR000058329
- 6alpha,9alpha-Difluoro-16alpha-hydroxyprednisolone 16,17-acetonide
- AKOS015963144
- C24-H30-F2-O6
- FLUOCINOLONE ACETONIDE [MART.]
- Fluocinolone acetonide intravitreal implant
- MSK2245-1000A
- Tox21_110869_1
- ACN-043362
- CCG-221165
- CS-2519
- DB00591
- FF15770
- FLUOCINOLONE ACETONIDE [USP-RS]
- FLUOCINOLONE ACETONIDE [WHO-DD]
- J1.414A
- NC00562
- RL04590
- CAS-67-73-2
- F0657
- Fluocinolone acetonide (JP15/USP/INN)
- Fluocinolone acetonide (JP18/USP/INN)
- Fluocinolone acetonide [USAN:USP:INN:JAN]
- NCGC00021301-04
- NCGC00021301-06
- NCGC00255654-01
- AS-13690
- BC214761
- BF176452
- NCI60_042042
- OTOVEL COMPONENT FLUOCINOLONE ACETONIDE
- SY057543
- Fluocinolone Acetonide (anti-inflammatory)
- FLUOCINOLONE ACETONIDE [GREEN BOOK]
- Fluocinolone acetonide, analytical standard
- ILUVIEN COMPONENT FLUOCINOLONE ACETONIDE
- SID:134222020
- AB1010906
- FLUOCINOLONE ACETONIDE [ORANGE BOOK]
- LS-118443
- 6.Alpha., 9.alpha.-Difluoro-16.alpha.-h
- B2095
- FLUOCINOLONE ACETONIDE [EP MONOGRAPH]
- FLUOCINOLONE ACETONIDE [USP IMPURITY]
- Fluocinolone acetonide for system suitability
- FT-0631295
- NS00008944
- 6a,9a-difluoro-16a-hydroxyprednisolone 16,17-acetonide
- FLUOCINOLONE ACETONIDE [USP MONOGRAPH]
- Isepamicine (Isepamycin, sch21420) Sulphate
- D01825
- J10113
- AB00383017-10
- AB00383017_11
- EN300-7410632
- Fluocinolone acetonide for system suitability CRS
- TRI-LUMA COMPONENT FLUOCINOLONE ACETONIDE
- 010F525
- 6-alpha,9-alpha-Difluoro-16-alpha-hydroxyprednisolone 16,17-acetonide
- A853087
- D005446
- F978955
- NEO-SYNALAR COMPONENT FLUOCINOLONE ACETONIDE
- Q924467
- SR-01000000109
- 2',1':4,5]indeno[1,2-d][1,3]dioxol-4-one
- 6alpha,9-Difluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione, cyclic 16,17-acetal with acetone
- Fluocinolone Acetonide Topical Solution USP, 0.01%
- Pregna-1,4-diene-3,20-dione, 6,9-difluoro-11,21-dihydroxy-16,17-((1-methylethylidene)bis(oxy))-, (6alpha,11beta,16alpha)-
- Pregna-1,4-diene-3,20-dione, 6alpha,9-difluoro-11beta,16alpha,17,21-tetrahydroxy-, cyclic 16,17-acetal with acetone
- SR-01000000109-2
- BRD-K94353609-001-21-6
- difluoro-hydroxy-(2-hydroxyacetyl)-tetramethyl-[?]one
- (6alpha,9alpha,11beta,16beta)-6,9-Difluoro-11,21-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]pregna-1,4-diene-3,20-dione
- Fluocinolone acetonide Solution in Acetonitrile, 1000ug/mL
- Fluocinolone acetonide Solution in Acetonitrile, 100ug/mL
- (1S,2S,4R,8S,9S,11S,12R,13S,19S)-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one
- (6alpha,11beta,16alpha)-6,9-Difluoro-11,21-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]pregna-1,4-diene-3,20-dione
- 6alpha,9alpha-Difluoro-11beta,16alpha,17alpha,21-tetrahydroxy-1,4-pregnadiene-3,20-dione 16,17-Acetonide
- 6alpha,9alpha-Difluoro-11beta,16alpha,17alpha,21-tetrahydroxy-1,4-pregnadiene-3,20-dione
- 6alpha,9alpha-Difluoro-16alpha-hydroxyprednisolone-16,17-acetonide
- (1S,2S,4R,8S,9S,11S,12R,13S,19S)-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icosa-14,17-dien-16-one
- (2S,6aS,6bR,7S,8aS,8bS,11aR,12aS,12bS)-2,6b-difluoro-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a,10,10-tetramethyl-6a,6b,7,8,8a,8b,11a,12,12a,12b-decahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4(2H)-one
- 4b,12-Difluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
- 6.alpha., 9.alpha.-Difluoro-16.alpha.-hydroxyprednisolone 16,17-acetonide
- 6.alpha.,9.alpha.-Difluoro-16.alpha.-hydroxyprednisolone 16,17-acetonide
- Fluocinolone acetonide, European Pharmacopoeia (EP) Reference Standard
- Fluocinolone acetonide, United States Pharmacopeia (USP) Reference Standard
- FS
- (4aS,4bR,5S,6aS,6bS,9aR,10aS,10bS,12S)-4b,12-difluoro-5-hydroxy-6b-(hydroxyacé
- Fluocinolone acetonide for system suitability, European Pharmacopoeia (EP) Reference Standard
- Fluocinolone Acetonide, Pharmaceutical Secondary Standard; Certified Reference Material
- WLN: T F5 E5 B666 GO IO RV AHTTTT&J A BF CQ E FVIQ H H OF -A&BHO -B&ACEF
- (1S,2S,4R,8S,9S,11S,12R,13S,19S)-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo(10.8.0.0^(2,9).0^(4,8).0^(13,18))icosa-14,17-dien-16-one
- (2S,6aS,6bR,7S,8aS,8bS,11aR,12aS,12bS)-2,6b-difluoro-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a,10,10-tetramethyl-1,2,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-4H-naphtho[
- (2S,6aS,6bR,7S,8aS,8bS,11aR,12aS,12bS)-2,6b-difluoro-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a,10,10-tetramethyl-6a,6b,7,8,8a,8b,11a,12,12a,12b-decahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4(2H)
- (4aS,4bR,5S,6aS,6bS,9aR,10aS,10bS,12S)-4b,12-Difluoro-5-hydroxy-6b-(hydroxyacetyl)-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H,8H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
- (4aS,4bR,5S,6aS,6bS,9aR,10aS,10bS,12S)-4b,12-difluoro-5-hydroxy-6b-(hydroxyacetyl)-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
- (4aS,4bR,5S,6aS,6bS,9aR,10aS,10bS,12S)-4b,12-difluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
- (6|_,11|_,16|_)-6,9-Difluoro-11,21-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]pregna-1,4-diene-3,20-dione
- (6|A,11|A,16|A)-6,9-Difluoro-11,21-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]pregna-1,4-diene-3,20-dione
- (6a,11b,16a)-6,9-Difluoro-11,21-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-pregna-1,4-diene-3,20-dione
- (6alpha,11beta,16alpha)-6,9-Difluoro-11,21-dihydroxy-16,17-((1-methylethylidene)bis(oxy))pregna-1,4-diene-3,20-dione
- 200-668-5
- 6.alpha.,16.alpha.,17,21-tetrahydroxypregna-1,4-diene-3,20-dione, cyclic 16,17-acetal with acetone
- 6.alpha.,9-Difluoro-11.beta.,16.alpha.,17,21-tetrahydroxypregna-1,4-diene-3,20-dione, cyclic 16,17-acetal with acetone
- 6|A,9|A-Difluoro-11|A,16|A,17|A,21-tetrahydroxy-1,4-pregnadiene-3,20-dione 16,17-acetonide
- 6alpha,9-Difluoro-11beta,21-dihydroxy-16alpha,17-(1-methylethylidenedioxy)pregna-1,4-diene-3,20-dione
- 6alpha,9-Difluoro-11beta,21-dihydroxy-16alpha,17-(isopropylidenebisoxy)pregna-1,4-diene-3,20-dione
- 6alpha,9-Difluoro-11beta,21-dihydroxy-16alpha,17-[(1-methylethylidene)bis(oxy)]pregna-1,4-diene-3,20-dione
- 6alpha,9-Difluoro-11beta,21-dihydroxy-16alpha,17-[(1-methylethylidene)bisoxy]pregna-1,4-diene-3,20-dione
- 6alpha,9-Difluoro-16alpha,17alpha-(isopropylidenebisoxy)-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
- 6alpha,9alpha-Difluoro-11beta,21-dihydroxy-16alpha,17alpha-(isopropylidenebisoxy)pregna-1,4-diene-3,20-dione
- 6alpha,9alpha-difluoro-11beta,21-dihydroxy-16alpha-17alpha-isopropylidenedioxypregna-1,4-diene-3,20-dione;
- 959-32-0
- Fluocinolone acetonide for peak identification, European Pharmacopoeia (EP) Reference Standard
- Fluocinolone acetonide; 6a,9-Difluoro-11ss,21-dihydroxy-16a,17-(1-methylethylidenedioxy)pregna-1,4-diene-3,20-dione
- Pregna-1,20-dione, 6,9-difluoro-11,12-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-, (6.alpha.,11.beta.,16.alpha.)-
- Pregna-1,20-dione, 6,9-difluoro-11,21-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)-, (6.alpha.,11.beta.,16.alpha.)-
- Pregna-1,20-dione, 6,9-difluoro-11,21-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-, (6.alpha.,11.beta.,16.alpha.)-
- Pregna-1,20-dione, 6.alpha.,9-difluoro-11.beta.,16.alpha.,17,21-tetrahydroxy-, cyclic 16,17-acetal with acetone
- Pregna-1,4-diene-3,20-dione, 6,9-difluoro-11,12-dihydroxy-16,17-((1-methylethylidene)bis(oxy))-, (6-alpha,11-beta,16-alpha)-
- PREGNA-1,4-DIENE-3,20-DIONE, 6,9-DIFLUORO-11,21-DIHYDROXY-16,17-((1-METHYLETHYLIDENE)BIS(OXY))-, (6.ALPHA.,11.BETA.,16.ALPHA.)-
- Pregna-1,4-diene-3,20-dione, 6,9-difluoro-11,21-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-, (6.alpha.,11.beta.,16.alpha.)-
- Pregna-1,4-diene-3,20-dione, 6.alpha.,9-difluoro-11.beta.,16.alpha.,17,21-tetrahydroxy-, cyclic 16,17-acetal with acetone
- Pregna-1,4-diene-3,20-dione, 6alpha,9-difluoro-11beta,16alpha,17,21-tetrahydroxy-, cyclic 16,17-acetal with acetone (8CI)